Evidence map›Paper›PMID 41645256›Full record

ReviewBiomedical engineering online2026

Beyond graphene: the MXene era in bioprinting.

Mananki Gutthedhar, Kishore Hazarika, Vijay Shankar Kumawat, N S Raviraja, Subrata Bandhu Ghosh, Kirthanashri S Vasanthan, Sanchita Bandyopadhyay-Ghosh

Abstract readReview
In one paragraph

Review in Biomedical engineering online, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. MoNanoscale advances · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mananki Gutthedhar *Manipal Centre for Biotherapeutics Research, Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India.
Kishore Hazarika *Engineered Biomedical Materials Research and Innovation Centre (EnBioMatRIC), Manipal University Jaipur, Jaipur, 303007, Rajasthan, India.
Vijay Shankar KumawatEngineered Biomedical Materials Research and Innovation Centre (EnBioMatRIC), Manipal University Jaipur, Jaipur, 303007, Rajasthan, India.
N S RavirajaManipal Centre for Biotherapeutics Research, Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India.
Subrata Bandhu GhoshEngineered Biomedical Materials Research and Innovation Centre (EnBioMatRIC), Manipal University Jaipur, Jaipur, 303007, Rajasthan, India.
Kirthanashri S VasanthanManipal Centre for Biotherapeutics Research, Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India. kirthanashri.sv@manipal.edu.
Sanchita Bandyopadhyay-GhoshEngineered Biomedical Materials Research and Innovation Centre (EnBioMatRIC), Manipal University Jaipur, Jaipur, 303007, Rajasthan, India. sanchitab.ghosh@jaipur.manipal.edu.

Funding

Manipal Research Board DoR/MRB/2023/SG-4
6 · The paper itself

Abstract

3D bioprinting is a revolutionary technology that has recently emerged in the area of tissue regeneration owing to its ability to create complex tissue and organs for replacement. The requirement of various tissue types to offer patient-specific treatments is challenging; bioprinting uses a specialized material called 'bioink', which helps to address the issue. MXene, a well-known two-dimensional nanomaterial, has been gaining interest recently. It has been identified as a promising candidate in the field of tissue engineering because of its unique combination of different properties, such as biocompatibility, mechanical strength, and electrical conductivity. These are essential properties for the development of the next-generation bioinks. In this review, we report a comprehensive analysis of the latest advances in MXene-based bioinks in 3D bioprinting over conventional tissue scaffolding, focused on the materials' properties and their role in tissue regeneration. We highlight the ability of MXene in bioink, where MXene has the capacity to enhance cell growth by providing a conducive microenvironment for electrically active tissue, additionally supporting the 3D construct for stability. MXene in bioinks is advancing toward the field of tissue engineering for its application in therapeutic applications.

Indexed as

BioprintingGraphiteNanostructuresAnimalsBiocompatible MaterialsHumansNitritesPrinting, Three-DimensionalTissue EngineeringTissue ScaffoldsTransition ElementsBiocompatible MaterialsGraphiteMXeneNitritesTransition Elements3D bioprintingBioinkMXeneTissue engineering

Identifiers

PMID41645256
PMCPMC12973904

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.